Delivery Order SPE2DB25D3003-SPE2DB25FPWVY
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,024.40 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on August 19, 2025, with ultimate completion by August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the vendor's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used across military and federal healthcare systems for disease prevention and immunization...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used across military and federal healthcare systems to support troop...
- The Defense Logistics Agency awarded a $11,463.02 delivery order to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine syringes on July 28, 2025, with completion targeted for July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,024.40 to AmerisourceBergen Drug Corp on January 13, 2025, for the supply of HAVRIX 720 Unit/0.5 ML syringes. This firm fixed-price, non-set-aside contract will be completed by January 14, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used in military and federal healthcare settings, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a $3,776.30 delivery order to AmerisourceBergen Drug Corp for Havrix 720 Unit/0.5 mL syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a pediatric hepatitis A vaccine delivery through AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,136.36 for 1,440 units/mL of HAVRIX vaccine syringes on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a single transaction under the company's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of HAVRIX 720 Unit/0.5 mL syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly utilized by military and federal healthcare systems for disease...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Havrix 720 Unit/0.5 ML syringes, with a ceiling value of $1,012.20 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,597.88 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringes. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Havrix 720 Unit/0.5 ML syringes, a hepatitis A vaccine product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,012.20 and is scheduled for completion by August 8, 2025. The contract utilizes no set-aside designation and represents a direct procurement of pharmaceutical products to support federal healthcare requirements. The place of...